X0306 4 2021-11-09 0 0000860730 HCA Healthcare, Inc. HCA 0001513235 Foster Jon M ONE PARK PLAZA NASHVILLE TN 37203 0 1 0 0 Group President Common Stock 2021-05-12 5 G 0 E 4919 0.00 D 4919 D Common Stock 2021-05-12 5 G 0 E 4919 0.00 A 48958 I By JMF Trust (Spouse and Robert Nagel, Co-Trustees) Common Stock 2021-05-12 5 G 0 E 4919 0.00 D 0 D Common Stock 2021-05-12 5 G 0 E 4919 0.00 A 4919 I By Spouse Common Stock 2021-05-13 5 G 0 E 4919 0.00 D 0 I By Spouse Common Stock 2021-05-13 5 G 0 E 4919 0.00 A 48958 I By LCF Trust (Reporting Person, Trustee) Common Stock 2021-11-09 4 M 0 33375 47.97 A 33375 D Common Stock 2021-11-09 4 F 0 17081 246.14 D 16294 D Common Stock 2021-11-11 4 S 0 9000 241.1695 D 7294 D Common Stock 2021-11-11 4 S 0 7000 242.1992 D 294 D Common Stock 2021-11-11 4 S 0 294 242.7866 D 0 D Common Stock 19985 I By JMF Family Trust (Spouse, Trustee) Stock Appreciation Right 47.97 2021-11-09 4 M 0 1500 0.00 D 2024-02-05 Common Stock 1500 0 D Stock Appreciation Right 47.97 2021-11-09 4 M 0 31875 0.00 D 2024-02-05 Common Stock 31875 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.73 to $241.72, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.74 to $242.68, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.75 to $242.82, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. /s/ Natalie Harrison Cline, Attorney-in-Fact 2021-11-12